Conjoint Professor Josh Davis

Conjoint Professor Josh Davis

Conjoint Professor

School of Medicine and Public Health

Career Summary

Biography

Dr Joshua S Davis, Infectious Diseases Physician and NHMRC Career Development Fellow

MBBS (Hons), DTM&H, FRACP, Grad Cert PopHealth, PhD

I did undergraduate medicine as the University of Sydney (1988-1993), then did basic physician training at Prince of Wales Hospital (Sydney), Royal Darwin Hospital, and John Hunter Hospital. I then did advanced training in Infectious Diseases at John Hunter and Royal Darwin Hospitals, and worked as a staff specialist in Infectious Diseases at John Hunter Hospital (2005), Royal Darwin Hospital (2006-2013) and John Hunter Hospital (2013 onwards). I established and led the liver clinic at RDH for 6 years, and am currently the Clinical Lead for the Viral Hepatitis stream at Hunter New England LHD.

I did a PhD at Menzies School of Health Research (epidemiology and pathophysiology of severe sepsis), and have been a post-doctoral research fellow there since 2011. I have been a conjoint senior lecturer at the University of Newcastle since 2013.

Executive Summary

I am an established and highly productive early career clinical researcher, as evidenced by my outputs since being awarded my PhD in 2011: over 60 peer-reviewed published papers, which have been collectively cited over 1000 times, giving me a 5-year h-index of 18, and research presentations at over 20 national and international scientific conferences. I have also attracted continuous people support funding from the NH&MRC from 2007 onwards (PhD Scholarship, ECF and CDF) and am currently a chief investigator on 4 NH&MRC project grants worth over $7 million and 5 current other competitive grants worth over $260,000.  I have achieved this whilst having an approximate half-time commitment as a senior clinician, and developing leadership roles in the Australian infectious diseases (ID) community. These include being elected as vice-president and president elect of the Australasian Society for Infectious Diseases (ASID), playing a key role in establishing the ASID clinical research network (CRN), of which I am now vice-chair, and being selected for the expert writing group of Therapeutic Guidelines: Antibiotic, Australia’s national antibiotic policy.


Keywords

  • Aboriginal Health
  • Clinical Trials
  • Infectious Diseases
  • Severe sepsis
  • Viral Hepatitis

Fields of Research

Code Description Percentage
111706 Epidemiology 20
110309 Infectious Diseases 80
Edit

Publications

For publications that are currently unpublished or in-press, details are shown in italics.


Journal article (75 outputs)

Year Citation Altmetrics Link
2017 Chaves NJ, Paxton GA, Biggs B-A, Thambiran A, Gardiner J, Williams J, et al., 'The Australasian Society for Infectious Diseases and Refugee Health Network of Australia recommendations for health assessment for people from refugee-like backgrounds: an abridged outline', MEDICAL JOURNAL OF AUSTRALIA, 206 310-315 (2017)
DOI 10.5694/mja16.00826
2017 Saeed K, Dryden M, Bassetti M, Bonnet E, Bouza E, Chan M, et al., 'Prosthetic joints: shining lights on challenging blind spots', INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 49 153-161 (2017)
DOI 10.1016/j.ijantimicag.2016.10.015
2017 Lora-Tamayo J, Senneville E, Ribera A, Bernard L, Dupon M, Zeller V, et al., 'The Not-So-Good Prognosis of Streptococcal Periprosthetic Joint Infection Managed by Implant Retention: The Results of a Large Multicenter Study', CLINICAL INFECTIOUS DISEASES, 64 1742-1752 (2017)
DOI 10.1093/cid/cix227
2017 Davis JS, Barrett T, Harris L, 'Knowledge of proprietary and generic drug names among hospital prescribers: time to mandate generic prescribing?', Internal Medicine Journal, 47 959-962 (2017) [C1]
DOI 10.1111/imj.13506
2017 Davies J, Li SQ, Tong SY, Baird RW, Beaman M, Higgins G, et al., 'Establishing contemporary trends in hepatitis B sero-epidemiology in an Indigenous population', PLOS ONE, 12 (2017)
DOI 10.1371/journal.pone.0184082
2017 Davis JS, Tapley A, Morgan S, van Driel ML, Magin PJ, 'Clinical experience of patients with hepatitis C virus infection among Australian GP trainees', MEDICAL JOURNAL OF AUSTRALIA, 206 309-309 (2017)
DOI 10.5694/mja16.01106
Co-authors Parker Magin
2017 Jones CA, Davis JS, Looke DFM, 'Death from an untreatable infection may signal the start of the post-antibiotic era', MEDICAL JOURNAL OF AUSTRALIA, 206 292-+ (2017)
DOI 10.5694/mja17.00077
Citations Scopus - 1
2017 Davis JS, Tapley A, Morgan S, van Driel ML, Magin PJ, 'Clinical experience of patients with hepatitis C virus infection among Australian GP trainees.', The Medical journal of Australia, 206 308-309 (2017)
DOI 10.5694/mja16.01106
Co-authors Parker Magin
2017 Udy AA, Dulhunty JM, Roberts JA, Davis JS, Webb SAR, Bellomo R, et al., 'Association between augmented renal clearance and clinical outcomes in patients receiving beta-lactam antibiotic therapy by continuous or intermittent infusion: a nested cohort study of the BLING-II randomised, placebo-controlled, clinical trial', INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 49 624-630 (2017)
DOI 10.1016/j.ijantimicag.2016.12.022
2017 Magin P, Tapley A, Morgan S, Davis JS, McElduff P, Yardley L, et al., 'Reducing early career general practitioners' antibiotic prescribing for respiratory tract infections: a pragmatic prospective non-randomised controlled trial.', Fam Pract, (2017)
DOI 10.1093/fampra/cmx070
Co-authors Parker Magin
2017 Harris PNA, McNamara JF, Paterson DL, Harris PNA, McNamara JF, Lye DC, et al., 'Proposed primary endpoints for use in clinical trials that compare treatment options for bloodstream infection in adults: a consensus definition', Clinical Microbiology and Infection, 23 533-541 (2017)

© 2016 European Society of Clinical Microbiology and Infectious Diseases Objectives To define standardized endpoints to aid the design of trials that compare antibiotic therapies... [more]

© 2016 European Society of Clinical Microbiology and Infectious Diseases Objectives To define standardized endpoints to aid the design of trials that compare antibiotic therapies for bloodstream infections (BSI). Methods Prospective studies, randomized trials or registered protocols comparing antibiotic therapies for BSI, published from 2005 to 2016, were reviewed. Consensus endpoints for BSI studies were defined using a modified Delphi process. Results Different primary and secondary endpoints were defined for pilot (small-scale studies designed to evaluate protocol design, feasibility and implementation) and definitive trials (larger-scale studies designed to test hypotheses and influence clinical practice), as well as for Staphylococcus aureus and Gram-negative BSI. For pilot studies of S. aureus BSI, a primary outcome of success at day 7 was defined by: survival, resolution of fever, stable/improved Sequential Organ Failure Assessment (SOFA) score and clearance of blood cultures, with no microbiologically confirmed failure up to 90 days. For definitive S. aureus BSI studies, a primary outcome of success at 90 days was defined by survival and no microbiologically confirmed failure. For pilot studies of Gram-negative BSI, a primary outcome of success at day 7 was defined by: survival, resolution of fever and symptoms related to BSI source, stable or improved SOFA score and negative blood cultures. For definitive Gram-negative BSI studies, a primary outcome of survival at 90 days supported by a secondary outcome of success at day 7 (as previously defined) was agreed. Conclusions These endpoints provide a framework to aid future trial design. Further work will be required to validate these endpoints with respect to patient-centred clinical outcomes.

DOI 10.1016/j.cmi.2016.10.023
Citations Web of Science - 2
2017 Davis JS, Mackrow C, Binks P, Fletcher W, Dettwiller P, Marshall C, et al., 'A double-blind randomized controlled trial of ibuprofen compared to placebo for uncomplicated cellulitis of the upper or lower limb.', Clin Microbiol Infect, 23 242-246 (2017)
DOI 10.1016/j.cmi.2017.02.036
2016 Tong SYC, Nelson J, Paterson DL, Fowler VG, Howden BP, Cheng AC, et al., 'CAMERA2-combination antibiotic therapy for methicillin-resistant Staphylococcus aureus infection: study protocol for a randomised controlled trial', TRIALS, 17 (2016)
DOI 10.1186/s13063-016-1295-3
Citations Scopus - 7Web of Science - 5
2016 Magin PJ, Morgan S, Tapley A, Henderson KM, Holliday EG, Ball J, et al., 'Changes in early-career family physicians' antibiotic prescribing for upper respiratory tract infection and acute bronchitis: A multicentre longitudinal study', Family Practice, 33 360-367 (2016) [C1]

© The Author 2016. Published by Oxford University Press. All rights reserved. Background. Inappropriate antibiotic prescription and subsequent antibacterial resistance are major ... [more]

© The Author 2016. Published by Oxford University Press. All rights reserved. Background. Inappropriate antibiotic prescription and subsequent antibacterial resistance are major threats to health worldwide. Objectives. We aimed to establish whether early-career 'apprenticeship-model' experience in family practice influences antibiotic prescribing for respiratory tract infections and to also establish other associations of antibiotic prescribing changes during this early-career experience. Methods. A longitudinal analysis (2010-2014) of a cohort study of Australian GP registrars' (vocational trainees') consultations. Registrars from five regional training programs recorded data from 60 consecutive consultations, once each 6-month training Term, including the diagnoses managed and medications prescribed. The outcomes were whether an antibiotic was prescribed for the diagnoses 'upper respiratory tract infection (URTI)' and 'acute bronchitis/bronchiolitis'. Generalized linear mixed modelling was used to account for repeated measures on registrars and to include the time component: 'Term'. Results. A total of 856 registrars recorded 108759 consultations, including 8715 'URTI' diagnoses (5.15% of diagnoses) and 2110 'acute bronchitis/bronchiolitis' diagnoses (1.25%). Antibiotics were prescribed in 16.3% [95% confidence interval (CI) 14.9-17.8] of URTI and 72.2% (95% CI 69.6-74.6) of acute bronchitis/bronchiolitis diagnoses. Moving from an earlier to later term did not significantly influence registrars' antibiotic prescribing for URTI [adjusted odds ratio (OR) 0.95; 95% CI 0.87, 1.04, P = 0.27] or acute bronchitis/bronchiolitis [OR 1.01 (95% CI 0.90-1.14), P = 0.86]. Significant associations of antibiotic prescribing for URTIs were the registrar being non-Australian educated, greater patient age, practices not privately billing patients, pathology being ordered, longer consultation duration and the registrar seeking in-consultation information or advice (including from their supervisor). Conclusions. Early-career experience/training failed to produce rational antibiotic prescribing for URTI and acute bronchitis/bronchiolitis. Our findings suggest that prescribing interventions could target the registrar-supervisor dyad.

DOI 10.1093/fampra/cmw025
Citations Scopus - 2Web of Science - 2
Co-authors Parker Magin, Liz Holliday
2016 van Driel ML, Morgan S, Tapley A, McArthur L, McElduff P, Yardley L, et al., 'Changing the Antibiotic Prescribing of general practice registrars: the ChAP study protocol for a prospective controlled study of a multimodal educational intervention', BMC FAMILY PRACTICE, 17 (2016)
DOI 10.1186/s12875-016-0470-7
Citations Scopus - 1Web of Science - 1
Co-authors Parker Magin, Patrick Mcelduff
2016 McGuinness SL, Whiting SE, Baird R, Currie BJ, Ralph AP, Anstey NM, et al., 'Nocardiosis in the tropical northern territory of Australia, 1997-2014', Open Forum Infectious Diseases, 3 1-25 (2016)

© 2016 The Author. Background: Nocardia is an opportunistic pathogen that can cause life-threatening disease. We aimed to characterise the epidemiological, microbiological and cl... [more]

© 2016 The Author. Background: Nocardia is an opportunistic pathogen that can cause life-threatening disease. We aimed to characterise the epidemiological, microbiological and clinical features of nocardiosis in the tropical north of Australia. Methods: We conducted a retrospective cohort study of nocardiosis diagnosed between 1997 and 2014. Population-based incidences were calculated using district population data. Results: Clinically significant nocardiosis was identified in sixty-one patients. The unadjusted population-based annual incidence of nocardiosis was 2.02 (95% confidence interval [CI] 1.55-2.60) per 100,000 people and was 1.7 (95% CI 0.96-2.90) fold higher in Indigenous compared with non-Indigenous persons (p=0.027). Of 61 patients, 47 (77%) had chronic lung disease, diabetes and/or hazardous alcohol consumption; 22 (36%) were immunocompromised; and 8 (13%) had no identified comorbidities. Disease presentations included pulmonary (69%; 42/61), cutaneous (13%, 8/61) and disseminated nocardiosis (15%, 9/61). The most commonly identified species were N. asteroides and N. cyriacigeorgica (each 11%). Linezolid was the only antimicrobial to which isolates were universally susceptible; 89% (48/54), 60% (32/53) and 48% (26/54) of isolates were susceptible to trimethoprim-sulfamethoxazole, ceftriaxone and imipenem, respectively. 18 patients (30%) required intensive care unit (ICU) admission and one-year mortality was 31%. Conclusions: The incidence of nocardiosis in tropical Australia is amongst the highest reported globally. Nocardiosis occurs in both immunocompromised and immunocompetent hosts, and is associated with high rates of ICU-admission, 1-year mortality and resistance to commonly-recommended antimicrobials. Diagnosis should be considered in patients with consistent clinical features, particularly if they are Indigenous or have chronic lung disease.

2016 Magin PJ, Morgan S, Tapley A, Davis JS, McArthur L, Henderson KM, et al., 'Reducing general practice trainees' antibiotic prescribing for respiratory tract infections: An evaluation of a combined face-To-face workshop and online educational intervention', Education for Primary Care, 27 98-105 (2016) [C1]

© 2016 Taylor & Francis. Over-prescription of antibiotics for non-pneumonia respiratory tract infections (RTIs) is a major concern in general practice. Australian general p... [more]

© 2016 Taylor & Francis. Over-prescription of antibiotics for non-pneumonia respiratory tract infections (RTIs) is a major concern in general practice. Australian general practice registrars (trainees) have inappropriately high rates of prescription of antibiotics for RTIs. The 'apprenticeship' educational model and the trainee- trainer relationship are drivers of this inappropriate prescribing. We aimed to reduce registrars' non-pneumonia RTI antibiotic prescribing via an educational intervention (a 90-min face-To-face workshop supported by online modules), complemented by delivery of the same intervention, separately, to their trainers. We conducted a pre-and post-intervention comparison of the registrars' intention to prescribe antibiotics for common RTIs using McNemar's test. We similarly tested changes in supervisors' intended prescribing. Prescribing intentions were elicited by responses to six written clinical vignettes (upper respiratory tract infection, otitis media, sore throat and three acute bronchitis vignettes). We found that, for registrars, there were statistically significant reductions in antibiotic prescribing for the sore throat (24.0% absolute reduction), otitis media (17.5% absolute reduction) and two of the three acute bronchitis (12.0% and 18.0% absolute reduction) vignettes. There were significant reductions in supervisors' antibiotic prescribing intentions for the same four vignettes. We conclude that our intervention produced a significant change in registrars' intention to prescribe antibiotics for non-pneumonia RTIs.

DOI 10.1080/14739879.2015.1106085
Citations Scopus - 3
Co-authors Parker Magin
2016 Jones CA, Davis JS, Looke DFM, 'The ASID test The Australasian Society for Infectious Diseases view on infectious diseases challenges in 2016 and beyond', MEDICAL JOURNAL OF AUSTRALIA, 204 250-+ (2016)
DOI 10.5694/mja16.00284
2016 McGuinness SL, Whiting SE, Baird R, Currie BJ, Ralph AP, Anstey NM, et al., 'Nocardiosis in the Tropical Northern Territory of Australia, 1997-2014.', Open Forum Infect Dis, 3 (2016) [C1]
DOI 10.1093/ofid/ofw208
2016 Roberts JA, Abdul-Aziz MH, Davis JS, Dulhunty JM, Cotta MO, Myburgh J, et al., 'Continuous versus intermittent ß-lactam infusion in severe sepsis: A meta-analysis of individual patient data from randomized trials', American Journal of Respiratory and Critical Care Medicine, 194 681-691 (2016) [C1]

© Copyright 2016 by the American Thoracic Society. Rationale: Optimization of ß-lactam antibiotic dosing for critically ill patients is an intervention that may improve outcomes... [more]

© Copyright 2016 by the American Thoracic Society. Rationale: Optimization of ß-lactam antibiotic dosing for critically ill patients is an intervention that may improve outcomes in severe sepsis. Objectives: In this individual patient data meta-analysis of critically ill patients with severe sepsis, we aimed to compare clinical outcomes of those treated with continuous versus intermittent infusion of ß-lactam antibiotics. Methods: We identified relevant randomized controlled trials comparing continuous versus intermittent infusion of ß-lactam antibiotics in critically ill patients with severe sepsis. We assessed the quality of the studies according to four criteria. We combined individual patient data from studies and assessed data integrity for common baseline demographics and study endpoints, including hospital mortality censored at 30 days and clinical cure. We then determined the pooled estimates of effect and investigated factors associated with hospital mortality in multivariable analysis. Measurements and Main Results: We identified three randomized controlled trials in which researchers recruited a total of 632 patients with severe sepsis. The two groups were well balanced in terms of age, sex, and illness severity. The rates of hospital mortality and clinical cure for the continuous versus intermittent infusion groups were 19.6% versus 26.3% (relative risk, 0.74; 95% confidence interval, 0.56-1.00; P = 0.045) and 55.4% versus 46.3% (relative risk, 1.20; 95% confidence interval, 1.03-1.40; P = 0.021), respectively. In a multivariable model, intermittent ß-lactam administration, higher Acute Physiology and Chronic Health Evaluation II score, use of renal replacement therapy, and infection by nonfermenting gram-negative bacilli were significantly associated with hospital mortality. Continuous ß-lactam administration was not independently associated with clinical cure. Conclusions: Compared with intermittent dosing, administration of ß-lactamantibioticsby continuous infusionincritically ill patientswith severe sepsis is associated with decreased hospital mortality.

DOI 10.1164/rccm.201601-0024OC
Citations Scopus - 35Web of Science - 28
2016 Davis JS, Sud A, O'Sullivan MVN, Robinson JO, Ferguson PE, Foo H, et al., 'Combination of Vancomycin and ß-Lactam Therapy for Methicillin-Resistant Staphylococcus aureus Bacteremia: A Pilot Multicenter Randomized Controlled Trial', Clinical Infectious Diseases, 62 173-180 (2016) [C1]

© 2015 The Author 2015. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail journals.permissions@oup... [more]

© 2015 The Author 2015. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail journals.permissions@oup.com. Background. In vitro laboratory and animal studies demonstrate a synergistic role for the combination of vancomycin and antistaphylococcal ß-lactams for methicillin-resistant Staphylococcus aureus (MRSA) bacteremia. Prospective clinical data are lacking. Methods. In this open-label, multicenter, clinical trial, adults with MRSA bacteremia received vancomycin 1.5 g intravenously twice daily and were randomly assigned (1:1) to receive intravenous flucloxacillin 2 g every 6 hours for 7 days (combination group) or no additional therapy (standard therapy group). Participants were stratified by hospital and randomized in permuted blocks of variable size. Randomization codes were kept in sealed, sequentially numbered, opaque envelopes. The primary outcome was the duration of MRSA bacteremia in days. Results. We randomly assigned 60 patients to receive vancomycin (n = 29), or vancomycin plus flucloxacillin (n = 31). The mean duration of bacteremia was 3.00 days in the standard therapy group and 1.94 days in the combination group. According to a negative binomial model, the mean time to resolution of bacteremia in the combination group was 65% (95% confidence interval, 41%-102%; P =. 06) that in the standard therapy group. There was no difference in the secondary end points of 28- and 90-day mortality, metastatic infection, nephrotoxicity, or hepatotoxicity. Conclusions. Combining an antistaphylococcal ß-lactam with vancomycin may shorten the duration of MRSA bacteremia. Further trials with a larger sample size and objective clinically relevant end points are warranted. Australian New Zealand Clinical Trials Registry: ACTRN12610000940077 (www.anzctr.org.au).

DOI 10.1093/cid/civ808
Citations Scopus - 15Web of Science - 17
2016 Jones CA, Davis JS, Looke DFM, 'The ASID test', MEDICAL JOURNAL OF AUSTRALIA, 204 250-251 (2016)
DOI 10.5694/mja16.00284
2016 McAuliffe GN, Baird RW, Hennessy J, Anstey NM, Davis JS, 'MALDI-TOF MS for identification of community-acquired Acinetobacter baumannii complex infections', PATHOLOGY, 48 100-102 (2016)
DOI 10.1016/j.pathol.2015.11.016
2015 Silva C, Ianna E, Jones T, Davis JS, 'Should patients with hepatitis C genotype 2/3 infection who are slow responders to pegylated interferon/ribavirin have treatment duration extended?', Hepatology, 62 660-661 (2015) [C3]
DOI 10.1002/hep.27601
2015 Dulhunty JM, Roberts JA, Davis JS, Webb SAR, Bellomo R, Gomersall C, et al., 'A Multicenter Randomized Trial of Continuous versus Intermittent ß-Lactam Infusion in Severe Sepsis.', American journal of respiratory and critical care medicine, 192 1298-1305 (2015) [C1]
DOI 10.1164/rccm.201505-0857oc
Citations Scopus - 47Web of Science - 47
2015 Davis JS, Van Hal S, Tong SYC, 'Combination Antibiotic Treatment of Serious Methicillin-Resistant Staphylococcus aureus Infections', SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 36 3-16 (2015) [C1]
DOI 10.1055/s-0034-1396906
Citations Scopus - 6Web of Science - 7
2015 Holmes NE, Tong SYC, Davis JS, van Hal SJ, 'Treatment of Methicillin-Resistant Staphylococcus aureus: Vancomycin and Beyond', SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 36 17-30 (2015) [C1]
DOI 10.1055/s-0034-1397040
Citations Scopus - 7Web of Science - 14
2015 Gear RJ, Carter JC, Carapetis JR, Baird R, Davis JS, 'Changes in the clinical and epidemiological features of group A streptococcal bacteraemia in Australia's Northern Territory', TROPICAL MEDICINE & INTERNATIONAL HEALTH, 20 40-47 (2015) [C1]
DOI 10.1111/tmi.12405
Citations Scopus - 7Web of Science - 5
2015 Blyth CC, Walls T, Cheng AC, Murray RJ, Fisher DA, Ingram PR, Davis JS, 'A comparison of paediatric and adult infectious diseases consultations in Australia and New Zealand', European Journal of Clinical Microbiology and Infectious Diseases, (2015) [C1]

The objective of this paper is to describe paediatric infectious diseases consultations across Australia and New Zealand. We surveyed infectious diseases physicians at 51 hospital... [more]

The objective of this paper is to describe paediatric infectious diseases consultations across Australia and New Zealand. We surveyed infectious diseases physicians at 51 hospitals over a period of 2 weeks in 2012. Compared with adult consults, paediatric consults were more frequently received from general paediatricians/physicians and intensive care, yet less frequently from surgeons and emergency. Respiratory, skin/soft tissue and bone/joint infections were the most frequent consultations in children. These data demonstrate the breadth of formal infectious diseases consults in children. Differences between paediatric and infectious diseases consultations need to be considered when planning both paediatric and adult physician training and future curriculum development.

DOI 10.1007/s10096-015-2391-0
2015 Tsai D, Jamal JA, Davis JS, Lipman J, Roberts JA, 'Interethnic Differences in Pharmacokinetics of Antibacterials', Clinical Pharmacokinetics, 54 243-260 (2015) [C1]

© 2014, Springer International Publishing Switzerland. Background: Optimal antibacterial dosing is imperative for maximising clinical outcome. Many factors can contribute to chan... [more]

© 2014, Springer International Publishing Switzerland. Background: Optimal antibacterial dosing is imperative for maximising clinical outcome. Many factors can contribute to changes in the pharmacokinetics of antibacterials to the extent where dose adjustment may be needed. In acute illness, substantial changes in important pharmacokinetic parameters such as volume of distribution and clearance can occur for certain antibacterials. The possibility of interethnic pharmacokinetic differences can further complicate attempts to design an appropriate dosing regimen. Factors of ethnicity, such as genetics, body size and fat distribution, contribute to differences in absorption, distribution, metabolism and elimination of drugs. Despite extensive previous work on the altered pharmacokinetics of antibacterials in some patient groups such as the critically ill, knowledge of interethnic pharmacokinetic differences for antibacterials is limited. Objectives: This systematic review aims to describe any pharmacokinetic differences in antibacterials between different ethnic groups, and discuss their probable mechanisms as well as any clinical implications. Methods: We performed a structured literature review to identify and describe available data of the interethnic differences in the pharmacokinetics of antibacterials. Results: We found 50 articles that met our inclusion criteria and only six of these compared antibacterial pharmacokinetics between different ethnicities within the same study. Overall, there was limited evidence available. We found that interethnic pha rmacokinetic differences are negligible for carbapenems, most ß-lactams, aminoglycosides, glycopeptides, most fluoroquinolones, linezolid and daptomycin, whereas significant difference is likely for ciprofloxacin, macrolides, clindamycin, tinidazole and some cephalosporins. In general, subjects of Asian ethnicity achieve drug exposures up to two to threefold greater than Caucasian counterparts for these antibacterials. This difference is caused by a comparatively lower volume of distribution and/or drug clearance. Conclusion: Interethnic pharmacokinetic differences of antibacterials are likely; however, the clinical relevance of these differences is unknown and warrants further research.

DOI 10.1007/s40262-014-0209-3
Citations Scopus - 8Web of Science - 9
2015 Commons RJ, Robinson CH, Gawler D, Davis JS, Price RN, 'High burden of diabetic foot infections in the top end of Australia: An emerging health crisis (DEFINE study)', DIABETES RESEARCH AND CLINICAL PRACTICE, 110 147-157 (2015) [C1]
DOI 10.1016/j.diabres.2015.09.016
Citations Scopus - 3Web of Science - 3
2015 Davies J, Bukulatjpi S, Sharma S, Caldwell L, Johnston V, Davis JS, 'Development of a Culturally Appropriate Bilingual Electronic App About Hepatitis B for Indigenous Australians: Towards Shared Understandings.', JMIR Research Protocols, 4 (2015) [C1]
DOI 10.2196/resprot.4216
Citations Web of Science - 2
2015 Tong SYC, Davis JS, Eichenberger E, Holland TL, Fowler VG, 'Staphylococcus aureus infections: Epidemiology, pathophysiology, clinical manifestations, and management', Clinical Microbiology Reviews, 28 603-661 (2015) [C1]

© 2015, American Society for Microbiology. All Rights Reserved. Staphylococcus aureus is a major human pathogen that causes a wide range of clinical infections. It is a leading c... [more]

© 2015, American Society for Microbiology. All Rights Reserved. Staphylococcus aureus is a major human pathogen that causes a wide range of clinical infections. It is a leading cause of bacteremia and infective endocarditis as well as osteoarticular, skin and soft tissue, pleuropulmonary, and device-related infections. This review comprehensively covers the epidemiology, pathophysiology, clinical manifestations, and management of each of these clinical entities. The past 2 decades have witnessed two clear shifts in the epidemiology of S. aureus infections: first, a growing number of health care-associated infections, particularly seen in infective endocarditis and prosthetic device infections, and second, an epidemic of community-associated skin and soft tissue infections driven by strains with certain virulence factors and resistance to ß-lactam antibiotics. In reviewing the literature to support management strategies for these clinical manifestations, we also highlight the paucity of high-quality evidence for many key clinical questions.

DOI 10.1128/CMR.00134-14
Citations Scopus - 177Web of Science - 178
2014 Davis JS, McMillan M, Swaminathan A, Kelly JA, Piera KE, Baird RW, et al., 'A 16-Year Prospective Study of Community-Onset Bacteremic Acinetobacter Pneumonia Low Mortality With Appropriate Initial Empirical Antibiotic Protocols', CHEST, 146 1038-1045 (2014) [C1]
DOI 10.1378/chest.13-3065
Citations Scopus - 13Web of Science - 13
2014 Davis JS, He V, Anstey NM, Condon JR, 'Long Term Outcomes Following Hospital Admission for Sepsis Using Relative Survival Analysis: A Prospective Cohort Study of 1,092 Patients with 5 Year Follow Up', PLOS ONE, 9 (2014) [C1]
DOI 10.1371/journal.pone.0112224
Citations Scopus - 12Web of Science - 12
2014 Engelman D, Hofer A, Davis JS, Carapetis JR, Baird RW, Giffard PM, et al., 'Invasive Staphylococcus aureus infections in children in tropical northern Australia', Journal of the Pediatric Infectious Diseases Society, 3 304-311 (2014)

© The Author 2014. Published by Oxford University Press on behalf of the Pediatric Infectious Diseases Society. Background. Despite a high burden of staphylococcal skin disease i... [more]

© The Author 2014. Published by Oxford University Press on behalf of the Pediatric Infectious Diseases Society. Background. Despite a high burden of staphylococcal skin disease in children and high incidence of Staphylococcus aureus bacteremia in adult Indigenous populations in northern Australia, there are few studies describing incidence or clinical information of invasive S aureus (ISA) infections in children. Methods. We conducted a retrospective review for all cases of S aureus bacteremia and sterile site infections, for children under 15 years, in northern Australia over a 4-year period (2007-2010). Cases were categorized as neonatal ( < 28 days) and pediatric (=28 days). Results. Forty-four cases (9 neonatal, 35 pediatric)were identified.The annual incidence of ISAwas 27.9 cases per 100 000 population. Among pediatric cases, the annual incidencewas significantly higher in the Indigenous (46.6) compared with the non-Indigenous (4.4) population (IRR: 10.6 [95%confidence interval, 3.8-41.4]). Pediatric infectionswere predominantly community-associated (86%).Clinical infection sites included osteoarticular (66%), pleuropulmonary (29%), and endocarditis (9%), and multifocal diseasewas common (20%). Eighty-three percent of pediatric cases presented with sepsis; 34%resulted in intensive care admission. Neonatal cases were all born prematurely; 89%were late-onset infections. Overall, 27%of infections were due to methicillin-resistant S aureus (MRSA).Comparedwithmethicillin-sensitive S aureus(MSSA), therewasnodifference in severityorpresentation in pediatricMRSA cases, but a higher proportion ofMRSA cases were readmitted. Conclusions. The annual incidence of ISA infection in this study is among the highest described, largely due to a disproportionate burden in Indigenous children. Infections are frequently severe and infection with MRSA is common. Children presenting with suspected ISA in this region should be treated empirically for MRSA.

DOI 10.1093/jpids/piu013
Citations Scopus - 3
2014 Darcy CJ, Minigo G, Piera KA, Davis JS, McNeil YR, Chen Y, et al., 'Neutrophils with myeloid derived suppressor function deplete arginine and constrain T cell function in septic shock patients', CRITICAL CARE, 18 (2014) [C1]
DOI 10.1186/cc14003
Citations Scopus - 31Web of Science - 26
2014 Parker C, Tong SYC, Dempsey K, Condon J, Sharma SK, Chen JWC, et al., 'Hepatocellular carcinoma in Australia's Northern Territory: high incidence and poor outcome', MEDICAL JOURNAL OF AUSTRALIA, 201 470-474 (2014) [C1]
DOI 10.5694/mja13.11117
Citations Scopus - 5Web of Science - 5
2014 Ingram PR, Cheng AC, Murray RJ, Blyth CC, Walls T, Fisher DA, Davis JS, 'What do infectious diseases physicians do? A 2-week snapshot of inpatient consultative activities across Australia, New Zealand and Singapore', CLINICAL MICROBIOLOGY AND INFECTION, 20 O737-O744 (2014) [C1]
DOI 10.1111/1469-0691.12581
Citations Scopus - 8Web of Science - 6
2014 Jeremiah CJ, Wills C, Bayly A, Perry GJ, Davis JS, Tong SY, Currie BJ, 'VANCOMYCIN DOSING NOMOGRAM FOR HAEMODIALYSIS PATIENTS', NEPHROLOGY, 19 513-514 (2014) [C3]
DOI 10.1111/nep.12270
Citations Scopus - 5Web of Science - 5
2014 Darcy CJ, Woodberry T, Davis JS, Piera KA, McNeil YR, Chen Y, et al., 'Increased plasma arginase activity in human sepsis: association with increased circulating neutrophils', CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 52 573-581 (2014) [C1]
DOI 10.1515/cclm-2013-0698
Citations Scopus - 4Web of Science - 4
2013 Davis JS, Kulatunga AC, Hajkowicz K, 'Outcomes for Indigenous and non-Indigenous patients who access treatment for hepatitis C in the Top End of the Northern Territory', MEDICAL JOURNAL OF AUSTRALIA, 199 23-23 (2013)
DOI 10.5694/mja13.10083
Citations Scopus - 2Web of Science - 2
2013 Deans AK, Boerma CJ, Fordyce J, De Souza M, Palmer DJ, Davis JS, 'Use of Royal Darwin Hospital emergency department by immigration detainees in 2011', MEDICAL JOURNAL OF AUSTRALIA, 199 776-778 (2013)
DOI 10.5694/mja13.10447
Citations Scopus - 5Web of Science - 4
2013 Pitman MC, Anstey NM, Davis JS, 'Eosinophils in Severe Sepsis in Northern Australia: Do the Usual Rules Apply in the Tropics?', CRITICAL CARE MEDICINE, 41 E286-E288 (2013)
DOI 10.1097/CCM.0b013e3182923755
Citations Scopus - 4Web of Science - 4
2013 Davies J, Littlejohn M, Locarnini SA, Whiting S, Hajkowicz K, Cowie BC, et al., 'The molecular epidemiology of hepatitis B in the Indigenous people of northern Australia', JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 28 1234-1241 (2013)
DOI 10.1111/jgh.12177
Citations Scopus - 21Web of Science - 19
2013 Dulhunty JM, Roberts JA, Davis JS, Webb SAR, Bellomo R, Gomersall C, et al., 'Continuous Infusion of Beta-Lactam Antibiotics in Severe Sepsis: A Multicenter Double-Blind, Randomized Controlled Trial', CLINICAL INFECTIOUS DISEASES, 56 236-244 (2013)
DOI 10.1093/cid/cis856
Citations Scopus - 153Web of Science - 138
2013 Dulhunty JM, Roberts JA, Davis JS, Webb SAR, Bellomo R, Gomersall C, et al., 'Reply to Soman et al', CLINICAL INFECTIOUS DISEASES, 57 323-+ (2013)
DOI 10.1093/cid/cit201
2013 Davies J, Tong SYC, Davis JS, 'Hepatitis D is rare or non-existent in hepatitis B virus-infected Indigenous Australians in the Northern Territory', AUSTRALIAN AND NEW ZEALAND JOURNAL OF PUBLIC HEALTH, 37 188-189 (2013)
DOI 10.1111/1753-6405.12040
2013 Dulhunty JM, Roberts JA, Davis JS, Webb SAR, Bellomo R, Gomersall C, et al., 'A protocol for a multicentre randomised controlled trial of continuous beta-lactam infusion compared with intermittent beta-lactam dosing in critically ill patients with severe sepsis: the BLING II study', CRITICAL CARE AND RESUSCITATION, 15 179-185 (2013)
Citations Scopus - 18Web of Science - 16
2013 Davis JS, McGloughlin S, Tong SYC, Walton SF, Currie BJ, 'A Novel Clinical Grading Scale to Guide the Management of Crusted Scabies', PLOS NEGLECTED TROPICAL DISEASES, 7 (2013)
DOI 10.1371/journal.pntd.0002387
Citations Scopus - 15Web of Science - 13
2012 Gordon CL, Whiting S, Haran G, Ward A, Coleman M, Baird R, et al., 'Entomophthoromycosis caused by Basidiobolus ranarum in tropical northern Australia', PATHOLOGY, 44 375-379 (2012)
DOI 10.1097/PAT.0b013e328353e912
Citations Scopus - 2Web of Science - 1
2012 Davies J, Gordon CL, Tong SYC, Baird RW, Davis JS, 'Impact of Results of a Rapid Staphylococcus aureus Diagnostic Test on Prescribing of Antibiotics for Patients with Clustered Gram-Positive Cocci in Blood Cultures', JOURNAL OF CLINICAL MICROBIOLOGY, 50 2056-2058 (2012)
DOI 10.1128/JCM.06773-11
Citations Scopus - 22Web of Science - 21
2012 Robins-Browne KL, Cheng AC, Thomas KAS, Palmer DJ, Currie BJ, Davis JS, 'The SMART-COP score performs well for pneumonia risk stratification in Australia's Tropical Northern Territory: a prospective cohort study', TROPICAL MEDICINE & INTERNATIONAL HEALTH, 17 914-919 (2012)
DOI 10.1111/j.1365-3156.2012.03006.x
Citations Scopus - 3Web of Science - 3
2011 Davis JS, Cheng AC, McMillan M, Humphrey AB, Stephens DP, Anstey NM, 'Sepsis in the tropical Top End of Australia's Northern Territory: disease burden and impact on Indigenous Australians', MEDICAL JOURNAL OF AUSTRALIA, 194 519-524 (2011)
Citations Scopus - 26Web of Science - 26
2011 Davis JS, Anstey NM, 'Is plasma arginine concentration decreased in patients with sepsis? A systematic review and meta-analysis', CRITICAL CARE MEDICINE, 39 380-385 (2011)
DOI 10.1097/CCM.0b013e3181ffd9f7
Citations Scopus - 29Web of Science - 30
2011 White HA, Davis JS, Kittler P, Currie BJ, 'Outpatient parenteral antimicrobial therapy-treated bone and joint infections in a tropical setting', INTERNAL MEDICINE JOURNAL, 41 668-673 (2011)
DOI 10.1111/j.1445-5994.2009.02136.x
Citations Scopus - 9Web of Science - 11
2011 Davis JS, Darcy CJ, Yeo TW, Jones C, McNeil YR, Stephens DP, et al., 'Asymmetric Dimethylarginine, Endothelial Nitric Oxide Bioavailability and Mortality in Sepsis', PLOS ONE, 6 (2011)
DOI 10.1371/journal.pone.0017260
Citations Scopus - 37Web of Science - 34
2011 Darcy CJ, Davis JS, Woodberry T, McNeil YR, Stephens DP, Yeo TW, Anstey NM, 'An Observational Cohort Study of the Kynurenine to Tryptophan Ratio in Sepsis: Association with Impaired Immune and Microvascular Function', PLOS ONE, 6 (2011)
DOI 10.1371/journal.pone.0021185
Citations Scopus - 20Web of Science - 16
2010 Davis JS, Cross GB, Charles PGP, Currie BJ, Anstey NM, Cheng AC, 'Pneumonia risk stratification in tropical Australia: does the SMART-COP score apply?', MEDICAL JOURNAL OF AUSTRALIA, 192 133-136 (2010)
Citations Scopus - 9Web of Science - 10
2010 Davis JS, Cheng AC, Currie BJ, Anstey NM, 'Pneumonia risk stratification in tropical Australia: does the SMART-COP score apply? Reply', MEDICAL JOURNAL OF AUSTRALIA, 192 543-543 (2010)
2010 Flint SM, Davis JS, Su J-Y, Oliver-Landry EP, Rogers BA, Goldstein A, et al., 'Disproportionate impact of pandemic (H1N1) 2009 influenza on Indigenous people in the Top End of Australia's Northern Territory', MEDICAL JOURNAL OF AUSTRALIA, 192 617-622 (2010)
Citations Scopus - 25Web of Science - 31
2010 Davis JS, Cheng AC, Currie BJ, Anstey NM, 'In reply', Medical Journal of Australia, 192 543 (2010)
2010 McMillan M, Davis JS, 'Acute hospital admission for sepsis: an important but under-utilised opportunity for smoking cessation interventions', Australian and New Zealand Journal of Public Health, 34 432-433 (2010)
DOI 10.1111/j.1753-6405.2009.00580.x
Citations Scopus - 1
2010 Winter S, Thomas JH, Stephens DP, Davis JS, 'Particulate face masks for protection against airborne pathogens - one size does not fit all: an observational study', CRITICAL CARE AND RESUSCITATION, 12 24-27 (2010)
Citations Web of Science - 4
2010 Carroll E, Page W, Davis JS, 'Screening for hepatitis B in East Arnhem Land: a high prevalence of chronic infection despite incomplete screening', INTERNAL MEDICINE JOURNAL, 40 784-787 (2010)
DOI 10.1111/j.1445-5994.2010.02316.x
Citations Scopus - 7Web of Science - 9
2010 Davis JS, Yeo TW, Piera KA, Woodberry T, Celermajer DS, Stephens DP, Anstey NM, 'Angiopoietin-2 is increased in sepsis and inversely associated with nitric oxide-dependent microvascular reactivity', CRITICAL CARE, 14 (2010)
DOI 10.1186/cc9020
Citations Scopus - 42Web of Science - 38
2009 Murray RJ, Davis JS, Burgner DP, 'The Australasian Society for Infectious Diseases guidelines for the diagnosis, management and prevention of infections in recently arrived refugees: an abridged outline', MEDICAL JOURNAL OF AUSTRALIA, 190 421-425 (2009)
Citations Scopus - 27Web of Science - 26
2009 Charles PGP, Davis JS, Grayson ML, 'Rocket Science and the Infectious Diseases Society of America/American Thoracic Society (IDSA/ATS) Guidelines for Severe Community-Acquired Pneumonia', CLINICAL INFECTIOUS DISEASES, 48 1796-1796 (2009)
DOI 10.1086/599227
Citations Scopus - 7Web of Science - 8
2009 Davis JS, Yeo TW, Thomas JH, McMillan M, Darcy CJ, McNeil YR, et al., 'Sepsis-associated microvascular dysfunction measured by peripheral arterial tonometry: an observational study', CRITICAL CARE, 13 (2009)
DOI 10.1186/cc8055
Citations Scopus - 34Web of Science - 31
2009 Davis JS, Darcy CJ, Piera K, McNeil YR, Woodberry T, Anstey NM, 'Ex-vivo changes in amino acid concentrations from blood stored at room temperature or on ice: Implications for arginine and taurine measurements', BMC Clinical Pathology, 9 (2009)

Background. Determination of the plasma concentrations of arginine and other amino acids is important for understanding pathophysiology, immunopathology and nutritional supplement... [more]

Background. Determination of the plasma concentrations of arginine and other amino acids is important for understanding pathophysiology, immunopathology and nutritional supplementation in human disease. Delays in processing of blood samples cause a change in amino acid concentrations, but this has not been precisely quantified. We aimed to describe the concentration time profile of twenty-two amino acids in blood from healthy volunteers, stored at room temperature or on ice. Methods. Venous blood was taken from six healthy volunteers and stored at room temperature or in an ice slurry. Plasma was separated at six time points over 24 hours and amino acid levels were determined by high-performance liquid chromatography. Results. Median plasma arginine concentrations decreased rapidly at room temperature, with a 6% decrease at 30 minutes, 25% decrease at 2 hours and 43% decrease at 24 hours. Plasma ornithine increased exponentially over the same period. Plasma arginine was stable in blood stored on ice, with a < 10% change over 24 hours. Plasma taurine increased by 100% over 24 hours, and this change was not prevented by ice. Most other amino acids increased over time at room temperature but not on ice. Conclusion. Plasma arginine concentrations in stored blood fall rapidly at room temperature, but remain stable on ice for at least 24 hours. Blood samples taken for the determination of plasma amino acid concentrations either should be placed immediately on ice or processed within 30 minutes of collection. © 2009 Davis et al; licensee BioMed Central Ltd.

DOI 10.1186/1472-6890-9-10
Citations Scopus - 18
2005 Davis JS, 'Management of bone and joint infections due to Staphylococcus aureus', INTERNAL MEDICINE JOURNAL, 35 S79-S96 (2005)
DOI 10.1111/j.1444-0903.2005.00982.x
Citations Scopus - 68Web of Science - 53
2004 Davis JS, Bourke P, 'Rhabdomyolysis associated with dengue virus infection', CLINICAL INFECTIOUS DISEASES, 38 E109-E111 (2004)
DOI 10.1086/392510
Citations Scopus - 55Web of Science - 48
2004 Davis JS, 'High-dose riboflavin for the prevention of migraine: can we afford to ignore it?', INTERNAL MEDICINE JOURNAL, 34 372-372 (2004)
DOI 10.1111/j.1445-5994.2004.00620.x
2001 Davis JS, Boyle MJ, Hannaford R, Watson A, 'Bupropion and serum sickness-like reaction', MEDICAL JOURNAL OF AUSTRALIA, 174 479-480 (2001)
Citations Scopus - 16Web of Science - 9
1997 Howard D, Davis JS, Pugsley D, Seymour T, Hoy W, 'Morphologic correlates of renal disease in a high risk Aboriginal community.', KIDNEY INTERNATIONAL, 51 1318-1318 (1997)
Citations Web of Science - 8
Show 72 more journal articles

Conference (2 outputs)

Year Citation Altmetrics Link
2017 Davis JS, Young MS, Lennox S, Jones T, Piera K, Oakley S, 'CHESS - curing hepatitis C: effect on the endothelium and cardiovascular risk', JOURNAL OF HEPATOLOGY (2017)
2015 Chaves NJ, Paxton GP, Smith M, Gardiner J, Biggs BA, Davis JS, 'REVISING THE 2009 AUSTRALASIAN SOCIETY OF INFECTIOUS DISEASES GUIDELINES FOR DIAGNOSIS, MANAGEMENT AND PREVENTION OF INFECTIONS IN NEWLY ARRIVED REFUGEES - NOT ONLY INFECTIONS AND NOT ONLY REFUGEES', INTERNAL MEDICINE JOURNAL (2015) [E3]
Edit

Grants and Funding

Summary

Number of grants 2
Total funding $52,734

Click on a grant title below to expand the full details for that specific grant.


20151 grants / $25,222

MERINO2 - A randomised controlled trial comparing two different antibiotics for blood stream infections caused by the 'ESCaPM' group of antibiotic resistant Gram negative bacteria$25,222

Funding body: John Hunter Hospital Charitable Trust

Funding body John Hunter Hospital Charitable Trust
Project Team Conjoint Professor Josh Davis, Professor Andrew Boyle, Patrick Harris, David Paterson
Scheme Research Grant
Role Lead
Funding Start 2015
Funding Finish 2015
GNo G1500781
Type Of Funding Grant - Aust Non Government
Category 3AFG
UON Y

20141 grants / $27,512

PIANO - Prosthetic Joint Infection in Australia and New Zealand Observational Study$27,512

Funding body: John Hunter Hospital Charitable Trust

Funding body John Hunter Hospital Charitable Trust
Project Team Conjoint Professor Josh Davis, Doctor Mark Loewenthal
Scheme Research Grant
Role Lead
Funding Start 2014
Funding Finish 2018
GNo G1400545
Type Of Funding Grant - Aust Non Government
Category 3AFG
UON Y
Edit

Research Supervision

Number of supervisions

Completed3
Current3

Current Supervision

Commenced Level of Study Research Title Program Supervisor Type
2016 Honours T cell responses to Salmonella Typhi in a human challenge model Medical Science, University of Newcastle Co-Supervisor
2016 PhD The molecular epidemiology of Gram negative environmental pathogens in Tropical Australia Microbiology, Menzies School of Health Research and Charles Darwin University Co-Supervisor
2014 PhD Relative Survival Analysis as a tool to understand disease outcomes in Australia's Northern Territory Statistics, Menzies School of Health Research and Charles Darwin University Co-Supervisor

Past Supervision

Year Level of Study Research Title Program Supervisor Type
2016 PhD ECHOCARDIOGRAPHIC SCREENING FOR RHEUMATIC HEART DISEASE IN NORTHERN AUSTRALIAN CHILDREN Epidemiology, Menzies School of Health Research and Charles Darwin University Co-Supervisor
2016 PhD Hepatitis B in Australia's Northern Territory: Understanding the True Story Epidemiology, Menzies School of Health Research and Charles Darwin University Principal Supervisor
2012 Honours The epidemiology of hepatocellular carcinoma in Australia's Northern Territory Epidemiology, The University of Melbourne Sole Supervisor
Edit

Research Projects

NETA - Neutrophil Extracellular Traps in Autoimmunity 2015 -

Neutrophil Extracellular Traps are a recently described mechanism of innate immunity. The Trauma group led by Prof Zsolt Balogh at HNE Health have recently demonstrated that a different type of NETosis involving mitochondrial DNA rather than cellular nuclear DNA occurs in the sterile inflammation occurring in the Systemic Inflammatory Response Syndrome. It seems plausible that the same process may occur in other forms of sterile inflammation such as the autoimmune diseases encountered in clinical Rheumatology. NETA is a preliminary observational study to determine whether NETosis is occurring in a range of inflammatory diseases and the type of NETosis that is occurring. The range of conditions includes rheumatoid arthritis, psoriatic arthritis, giant cell arteritis, gout, bacterial sepsis. The collaborators include A/Prof Stephen Oakley, Prof Zsolt Balogh, Prof Phil Hansbro and Dr Joshua Davis.

Collaborators

Name Organisation
Conjoint Professor Josh S Davis
Professor Zsolt Janos Balogh University of Newcastle

CHESS 2015 - 2016


Edit

Conjoint Professor Josh Davis

Position

Conjoint Professor
School of Medicine and Public Health
Faculty of Health and Medicine

Contact Details

Email josh.davis@newcastle.edu.au
Link Personal webpage
Edit